Research study Program year 2021 Source: CMS Open Payments

A Phase 1, open-label, dose finding study of CC-93

Research payments

$1,457,918

10 payments

Through program year 2021, $1,457,918 in research payments was reported against A Phase 1, open-label, dose finding study of CC-93, across 10 payments, paid by Celgene Corporation.

Paid by: Celgene Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$1,457,918	10

Breakdown

Who paid Research payments · program year 2021

Celgene Corporation $1,457,918 10 payments

Who received the money Research payments · program year 2021

Langley Porter Psychiatric Hospital Teaching hospital · CA $652,215 1 payment
Swedish Medical Center Teaching hospital · WA $220,734 1 payment
University Of Alabama Hospital Teaching hospital · AL $206,840 1 payment
Lee Daeyeol Mms Organisation paid for research $146,968 1 payment
Yale University Organisation paid for research $143,567 2 payments
Dana Farber Cancer Institute Organisation paid for research $43,450 1 payment
Mount Sinai School Of Medicine Organisation paid for research $23,919 1 payment
Emory University Hospital Teaching hospital · GA $18,225 1 payment
Henry Ford Hospital Teaching hospital · MI $2,000 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.